

4-(m-Tolylamino)pyridine-3-sulfonamide (CAS 72811-73-5) is a pivotal intermediate in the API intermediates market, primarily serving as the penultimate precursor for the synthesis of Torsemide, a potent loop diuretic, where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are required to maintain strict impurity profiles. 4-(3-Methylphenyl)aminopyridine-3-sulfonamide facilitates advanced nucleophilic aromatic substitution processes, reflecting a significant trend toward strategic global sourcing as CDMOs prioritize custom synthesis services that offer robust analytical validation to meet evolving Pharmacopoeial standards. Torsemide Related Compound A remains a critical benchmark in the global supply chain, with increasing demand for bulk chemical supplier partnerships that can deliver consistent crystalline morphology and high-performance yields (Pharma/API purity 99% | General Industry purity 98%) while navigating complex regulatory landscapes and environmental compliance. We are an established global intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-(M-TOLYLAMINO) PYRIDINE-3-SULFONAMIDE COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

4-(m-Tolylamino)pyridine-3-sulfonamide (CAS 72811-73-5) is a pivotal intermediate in the API intermediates market, primarily serving as the penultimate precursor for the synthesis of Torsemide, a potent loop diuretic, where high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) are required to maintain strict impurity profiles. 4-(3-Methylphenyl)aminopyridine-3-sulfonamide facilitates advanced nucleophilic aromatic substitution processes, reflecting a significant trend toward strategic global sourcing as CDMOs prioritize custom synthesis services that offer robust analytical validation to meet evolving Pharmacopoeial standards. Torsemide Related Compound A remains a...

Chemical Properties & Specifications
P261, P264+P265, P272, P280, P302+P352, P305+P351+P338, P321, P333+P317, P337+P317, P362+P364, and P501
Skin Sens. 1 (96.4%)
Eye Irrit. 2A (100%)
An important building block and critical intermediate primarily used in the multi-step convergent synthesis of the potent loop diuretic torsemide (torasemide) for the treatment of hypertension and edema
A certified reference material or pharmaceutical secondary standard utilized as torsemide related compound A for analytical testing, impurity profiling, and quality control in pharmaceutical research and development
A functionalized pyridine-3-sulfonamide derivative employed in academic and industrial research for the development of complex heterocyclic molecules and medicinal chemistry applications.
4-(m-Tolylamino) pyridine-3-sulfonamide is a high-purity chemical intermediate primarily used in the synthesis of the loop diuretic Torsemide (Torasemide)
This compound is predominantly used in the pharmaceutical industry for the production of active pharmaceutical ingredients (APIs)
It is slightly soluble in DMSO and methanol and is typically used in the synthesis of solid-dose oral medications or injectable diuretics
Standard specifications include CAS number 72811-73-5, a purity level of ≥98% (HPLC), and availability of documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...